New lutein product to fight AMD

- Last updated on GMT

Related tags: Macular degeneration

A new lutein product, called Xantiol, has been created by the
French company Nutralica and designed to help treat age-related
macular degeneration (AMD).

A new lutein product, called Xantiol, has been created by the French company Nutralica and designed to help treat age-related macular degeneration (AMD).

Nutralica is a new company, created in March of this year after 18 months of research and development. One of the company's principal partners is the Brussels-based research organisation CERDEN, whose expertise in the field of nutritherapy - treating diseases with nutrients - was one of the driving forces behind Xantiol.

The lutein supplement - which also contains DHA, vitamin E, zinc and selenium - will be available in Germany and the Benelux countries, through the UNDA laboratory, from August of this year, with distribution to other European countries planned in due course.

A second supplement brand, Lipobiol, a treatment for diabetes and associated cardiovascular problems, will be launched later this year.

Both Xantiol and Lipobiol will be available only through scientific laboratories and national pharmaceutical distribution networks.

Related topics: Suppliers, Markets and Trends

Related news

Follow us

Featured Events

View more

Products

View more

Webinars